We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AstraZeneca's Legal Troubles Continue To Mount

Law360 (December 21, 2006, 12:00 AM EST) -- Days after the European Patent Office rejected a key substance-of-matter patent covering drug giant AstraZeneca’s blockbuster heartburn drug Nexium, antitrust challenges continue to mount over the drug in the United States.

Lawsuits continue to trickle in alleging that AstraZeneca has illegally controlled the market by shifting its support to Nexium from Prilosec as Prilosec lost patent protection.

Two suits were filed this week in the U.S. District Court for the District of Columbia. Louisiana Wholesale Drug Co. Inc., a wholesaler which reportedly covers 65% of independent...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.